Related Experiment Video
Updated: Jun 12, 2026
05:37
Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes
Published on: April 4, 2025
Structural insights into G-quadruplexes: towards new anticancer drugs
1College of Pharmacy, The University of Arizona, 1703 E. Mabel St., Tucson, AZ 85721, USA. yang@pharmacy.arizona.edu
Future Medicinal Chemistry
|June 22, 2010
Summary
DNA G-quadruplexes are unique structures in G-rich DNA found in important genomic regions. These structures are emerging as key targets for novel anticancer drug development.
Area of Science:
- Molecular Biology
- Genetics
- Drug Discovery
Background:
- DNA G-quadruplexes are secondary structures formed in guanine-rich sequences.
- These structures are prevalent in biologically significant regions like human telomeres and oncogene promoters.
- DNA G-quadruplexes represent a novel class of molecular targets for anticancer therapeutics.
Purpose of the Study:
- To discuss recent structural studies of biologically relevant G-quadruplexes.
- To review advances in the design and development of G-quadruplex-interactive drugs.
Main Methods:
- Structural studies of G-quadruplexes from human telomeres and oncogene promoters.
- Analysis of G-quadruplex-interactive drug design and development.
Main Results:
- G-quadruplexes form globularly folded nucleic acid structures under physiological conditions.
- Intramolecular G-quadruplex structures exhibit diversity, suggesting differential regulation and targeting.
- Recent progress highlights potential for targeted anticancer therapies.
Conclusions:
- DNA G-quadruplexes are promising targets for novel anticancer drug development.
- Structural diversity of G-quadruplexes allows for specific targeting by drugs and proteins.
- Further research into G-quadruplex structures will advance therapeutic strategies.
Related Concept Videos
02:27DNA Base Pairing
Erwin Chargaff’s rules on DNA equivalence paved the way for the discovery of base pairing in DNA. Chargaff’s rules state that in a double-stranded DNA molecule,
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
00:55DNA Helicases
DNA unwinding helicase enzymes are a type of motor protein. Motor proteins can translocate along filaments or polymers using energy generated from ATP hydrolysis. Helicases are involved in all the important cellular processes where DNA unwinding is required, such as DNA replication, repair, recombination, and transcription. They are present in all living organisms, but vary in their structure, function, and mechanism of action. For example, in prokaryotes, DnaB helicase binds and translocates...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...